These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14186532)

  • 21. EFFECT OF PLASMIN ON FIBRINOGEN AND FIBRIN.
    GAJEWSKI J; ALEXANDER B
    Am J Physiol; 1964 Jan; 206():79-82. PubMed ID: 14111457
    [No Abstract]   [Full Text] [Related]  

  • 22. [Quantitative determination of protector activity of fibrinogen tryptic hydrolysates].
    Musialkivs'ka AO; Pozdniakova TM; Platonova TM; Khomenko VM
    Ukr Biokhim Zh; 1977; 49(4):118-23. PubMed ID: 19861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ON KINETICS OF THE ENZYMATIC CONVERSION OF FIBRINOGEN TO FIBRIN].
    BRESTKIN AP; ZAIDMAN RA; MAIDANOVA NV; SAGAL AA
    Dokl Akad Nauk SSSR; 1964 Sep; 158():467-70. PubMed ID: 14262625
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fibrin-fragment D-protector equilibrium system. Quantitative determination of protector activity].
    Ugarova TP; Belitser VA
    Ukr Biokhim Zh (1978); 1978; 50(3):357-63. PubMed ID: 664050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 26. [XANTHOPROTEIN REACTION IN THE DETERMINATION OF FIBRINOGEN].
    MOHAROS J
    Kiserl Orvostud; 1964 Apr; 16():206-7. PubMed ID: 14155571
    [No Abstract]   [Full Text] [Related]  

  • 27. [Quantitative determination of the inhibitory effect of fibrinogen and its tryptic proteolysis products on fibrin polymerization].
    Mal'eva GV; Veretskaia TV
    Ukr Biokhim Zh; 1969; 41(6):691-7. PubMed ID: 5372742
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of low-molecular peptides on the transformation of fibrinogen into fibrin].
    Levitskaia NG; Kleĭmenov AN; Petrosian MT; Rozenfel'd MA; Kalikhevich VN
    Biull Eksp Biol Med; 1987 Aug; 104(8):190-2. PubMed ID: 3620679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [EFFECT OF CALCIUM, IONIC STRENGTH AND TEMPERATURE ON THE ENZYMATIC PHASE OF FIBRINOGEN CONVERSION TO FIBRIN].
    GRIAZNUKHINA EA
    Ukr Biokhim Zh; 1964; 36():898-906. PubMed ID: 14298739
    [No Abstract]   [Full Text] [Related]  

  • 30. Does topology drive fiber polymerization?
    Huang L; Hsiao JP; Powierza C; Taylor RM; Lord ST
    Biochemistry; 2014 Dec; 53(49):7824-34. PubMed ID: 25419972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. THE ACTION OF PLASMIN ON FIBRINOGEN ADN FIBRIN. I. CHANGES IN THE N-TERMINAL RESIDUES.
    MILLS DA; COYNE R; POLLARA B; VONKORFF RW
    Biochim Biophys Acta; 1964 Jun; 86():527-34. PubMed ID: 14192904
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mechanism of inhibition of fibrin polymerization by fibrinogen and its active fragments].
    Belitser VA; Varetskaia TV; Kosterin SA
    Biokhimiia; 1980 Jan; 45(1):157-64. PubMed ID: 7213830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of complementary E2 and D2 centers in the reaction between fibrin and fibrinogen].
    Ugarova TP; Kalikhevich VN; Ardemasova ZA; Belitser VA
    Biokhimiia; 1987 Feb; 52(2):255-63. PubMed ID: 3567249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Formation and polymerization of fibrin monomer].
    BELITSER VA; BELIK IaV
    Dokl Akad Nauk SSSR; 1953 Aug; 91(4):895-8. PubMed ID: 13095303
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical perspectives in studies of trypsin-trypsin inhibitor system, plasma kinins and fibrinogen degradation products in peptic ulcer].
    Makarevich IaA; Balashov VI; Panova TN; Panov AA; Pelov EIa
    Ter Arkh; 1977; 49(5):89-92. PubMed ID: 877904
    [No Abstract]   [Full Text] [Related]  

  • 36. [The role of D2-E2 centers of interdomain binding of fibrin monomer during fibrinogen co-polymerization with an NH2-terminal disulfide knot of fibrin].
    Pozdniakova TM; Rybachuk VN; Ugarova TP
    Biokhimiia; 1987 Apr; 52(4):592-8. PubMed ID: 3593791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [IMPORTANCE OF BLOOD LEVELS OF FIBRIN IN THE INTERPRETATION OF THE MAXIMUM AMPLITUDE OF THROMBODYNOGRAMS].
    SAMAMA M; PROST RJ; MARCHAL G
    Hemostase; 1963; 3():165-76. PubMed ID: 14050813
    [No Abstract]   [Full Text] [Related]  

  • 39. THE PLATELET-FIBRIN RELATIONSHIP IN HUMAN BLOOD CLOTS: AN ULTRASTRUCTURAL STUDY UTILIZING FERRITIN-CONJUGATED ANTI-HUMAN FIBRINOGEN ANTIBODY.
    WHITE JG; KRIVIT W; VERNIER RL
    Blood; 1965 Feb; 25():241-57. PubMed ID: 14267700
    [No Abstract]   [Full Text] [Related]  

  • 40. [Electrophoretic fractions and NH2-terminal amino acids of high-molecular tryptic fragments of fibrinogen and fibrin].
    Lugovskoĭ EV; Pozdniakova TM; Varetskaia TV; Derzskaia SG; Tolstykh VM
    Ukr Biokhim Zh; 1976; 48(6):743-9. PubMed ID: 1014141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.